Capmatinib is a potent ATP-competitive MET inhibitor. It blocks AKT/ERK signaling by inhibiting MET, reducing tumor growth.
Capmatinib (INC280) IC50 for Cell-based and Cell-free Assays
Comprehensive IC50 Values for Capmatinib (INC280) Across Cell-free Enzyme Inhibitory Profiles and Cell-based Functional Assays.
Jump to
- Capmatinib (INC280) Mechanism of Action: MET Inhibition in Non-Small Cell Lung Cancer Cells Research
- Capmatinib (INC280) Clinical Trials
- Capmatinib (INC280): Selectivity & Specificity
- Capmatinib (INC280) Working Concentration | Cell Culture | Treatment
- Capmatinib (INC280) Solubility in DMSO
- Capmatinib (INC280) Stock Solution
- Capmatinib (INC280) Storage
- Capmatinib (INC280) Stability
- Capmatinib (INC280) Combination Database
- Capmatinib (INC280) Molecular Weight
- Capmatinib (INC280) SMILES
- Capmatinib (INC280) CAS Number
- Capmatinib (INC280) Chemical Structure (2D and 3D)
- Capmatinib (INC280) MedChemExpress (HY-13404)? Try a better option.
- Capmatinib (INC280) Cayman (20056)? Try a better option.
- Capmatinib (INC280) APExBIO (A8448)? Try a better option.
- Capmatinib (INC280) SDS｜MSDS